We'll send your prescription to a local pharmacy
GLP-1 receptor agonists like semaglutide (Ozempic, Wegovy) and tirzepatide (Mounjaro, Zepbound) effectively manage type 2 diabetes and promote weight loss, but their gastrointestinal effectsincluding nausea, vomiting, and diarrheacan disrupt fluid and electrolyte balance
But while the world is going to just continue to yell about the weight loss numbers, I want to discuss the fact that this drug seems to be about as close to a metabolic fix it all, unlike anything weve seen before
Our research shows shopper priorities are evolving quickly and dramatically. GLP-1 drugs usually are taken for 6 to 12 months, with just over 48% of current weight-loss users staying on the medication for a full year, Circana said, adding that cost is the chief reason users stop taking GLP-1s
No medication can guarantee a specific amount of weight loss or metabolic improvement